LNA antagonists targeting the androgen receptor

Details for Australian Patent Application No. 2008329327 (hide)

Owner Enzon Pharmaceuticals, Inc. Santaris Pharma A/S

Inventors Worm, Jesper

Agent Griffith Hack

Pub. Number AU-A-2008329327

PCT Pub. Number WO2009/068033

Priority 60/990,125 26.11.07 US

Filing date 26 November 2008

Wipo publication date 4 June 2009

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

3 June 2010 PCT application entered the National Phase

  PCT publication WO2009/068033 Priority application(s): WO2009/068033

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008329344-Lining support for underground mining and tunneling

2008329318-Intervertebral implant